Costa-Machado, Luis Filipe http://orcid.org/0000-0002-1716-6563
Garcia-Dominguez, Esther http://orcid.org/0000-0001-6276-4944
McIntyre, Rebecca L.
Lopez-Aceituno, Jose Luis
Ballesteros-Gonzalez, Álvaro http://orcid.org/0000-0002-2330-3624
Tapia-Gonzalez, Andrea
Fabregat-Safont, David http://orcid.org/0000-0002-2918-227X
Eisenberg, Tobias http://orcid.org/0000-0003-3559-1130
Gomez, Jesús http://orcid.org/0000-0002-8567-8907
Plaza, Adrian http://orcid.org/0000-0002-5316-5090
Sierra-Ramirez, Aranzazu
Perez, Manuel http://orcid.org/0000-0001-8839-6895
Villanueva-Bermejo, David
Fornari, Tiziana
Loza, María Isabel
Herradon, Gonzalo
Hofer, Sebastian J. http://orcid.org/0000-0002-0756-0014
Magnes, Christoph http://orcid.org/0000-0002-5153-7444
Madeo, Frank
Duerr, Janet S. http://orcid.org/0000-0002-7582-2901
Pozo, Oscar J. http://orcid.org/0000-0002-1735-9728
Galindo, Maximo-Ibo http://orcid.org/0000-0001-8448-9760
del Pino, Isabel
Houtkooper, Riekelt H.
Megias, Diego
Viña, Jose
Gomez-Cabrera, Mari Carmen http://orcid.org/0000-0003-4000-1684
Fernandez-Marcos, Pablo J. http://orcid.org/0000-0003-3515-4125
Funding for this research was provided by:
Fundación Científica Asociación Española Contra el Cáncer (LABAE18008FERN)
Ministerio de Educación, Cultura y Deporte (MGS/2021/15)
Generalitat Valenciana (OP ERDF, CIDENGENT/2019/044)
Article History
Received: 23 February 2022
Accepted: 2 May 2023
First Online: 15 May 2023
Competing interests
: F.M. is scientific cofounder of Samsara Therapeutics, a company that develops novel pharmacological autophagy inducers. F.M. and T.E. have equity interests in and are advisors of TLL The Longevity Labs GmbH. The remaining authors declare no competing interests.